Femarelle By Se-cure Pharmaceuticals Overview & Drug Interactions

Check For Interactions With Femarelle

Supplement: Femarelle by Se-cure Pharmaceuticals

Femarelle Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Femarelle by Se-cure Pharmaceuticals

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Femarelle. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about Femarelle interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 56

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Tofu extract
322 mg
Tofu --
Flax
108 mg
Flax --

Other Ingredients:
Cellulose capsules


Label Statments:


Formulation
- Femarelle(R) contains no estrogen and is not an isoflavone extract.
Suggested/Recommended/Usage/Directions
- Suggested Use: A dietary supplement for the relief of menopausal symptoms and to support bone mineral content.* Recommended intake: 1 capsule, twice daily morning and evening; can be taken with or without food.
Precautions
- Warnings: If you are pregnant, nursing or taking prescription drugs, consult your healthcare practitioner prior to use.
- Do not use if seal is cut, torn or broken.
General Statements
- Capsules are individually sealed in blister packs.
- MADE IN ISRAEL
Storage
- Store in a cool dry place.
FDA Statement of Identity
- DIETARY SUPPLEMENT
Formula
- A Natural SERM for Menopuse & Bone Health*
- Kosher
- Clinically proven relief of menopausal symptoms and promotion of bone health.*
FDA Disclaimer Statement
- Studies have shown that Femarelle(R) alleviates menopausal symptoms and promotes bone health.*
- * These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Brand IP Statement(s)
- Femarelle(R) is a high-quality product using standardized ingredients produced in consistent batches, and manufactured according to strict manufacturing practices:
- Published clinical studies have shown that Femarelle(R) alleviates menopausal symptoms such as hot flashes, sleep disturbances, night sweats, joint and muscle discomfort.
- Furthermore, Femarelle(R) supports bone mineral density and promotes bone health.*
Seals/Symbols
- ISO 14001:2004 IQC Institute of Quality & Control Certified Environmental Management System
- ISO 9001:2008 IQC Institute of Quality & Control Certified Environmental Management System
- G.M.P Good Manufacturing Practices

Brand Information

See all products by this brand

Distributed
Name IFS
Street Address 4346 Belgium Blvd
City Kansas City
State MO
ZipCode 64150-1704
For information or orders please call
Phone Number 1-877-336-2735
or you can order online at
Web Address www.femarelle.us
Manufacturer
Name Se-cure Pharmaceuticals Ltd.

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.